ALMS
ALUMIS INC.
NASDAQ · Healthcare · Biotechnology · US
$6.51
+0.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 105.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.86x
- Price / sales
- 113.81x
- Price / cash flow
- -2.40x
Enterprise value
- Enterprise value
- $376.1M
- EV / sales
- 50.84x
- EV / EBITDA
- -0.85x
- EV / EBIT
- -0.82x
- Market cap
- $842.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026